ReviewFrontiers in microbiology2024
Exploring the complex interplay: gut microbiome, stress, and leptospirosis.
Review in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 16 citations in OpenAlex.
- Association between anxiety symptoms on risky e-biking riding behavior among adolescents: based on gut-brain axis.Comprehensive psychoneuroendocrinology · 2026Article
- Combined effects of calorie restriction and chronic stress on systemic inflammation and gut microbiota in rats exposed toBrain, behavior, & immunity - health · 2025Article
- Dysbiosis and Neurodegeneration in ALS: Unraveling the Gut-Brain Axis.Neuromolecular medicine · 2025Review
- Serogroup Distribution ofMicroorganisms · 2025Article
- Geographical factors and air raid alarms influence leptospirosis epidemiology in Ukraine (2018-2023).One health (Amsterdam, Netherlands) · 2024Article
- Comprehensive Analysis of Antiphage Defense Mechanisms: Serovar-Specific Patterns.Antibiotics (Basel, Switzerland) · 2024Article
- ExploringMicroorganisms · 2024Article
- Microplastics and human health: unveiling the gut microbiome disruption and chronic disease risks.Frontiers in cellular and infection microbiology · 2024Review
- Molecular mechanisms and therapeutic possibilities of short-chain fatty acids in posttraumatic stress disorder patients: a mini-review.Frontiers in neuroscience · 2024Review
- Current treatment options for leptospirosis: a mini-review.Frontiers in microbiology · 2024Review
- Surveillance of human leptospirosis infections in Ukraine between 2018 and 2023.Frontiers in public health · 2024Article
- AMR mechanisms inFrontiers in cellular and infection microbiology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leptospirosis, a re-emerging zoonotic disease, remains a significant global health concern, especially amid floods and disasters such as the Kakhovka Dam destruction. As is known, the stress that occurs in the conditions of military conflicts among civilian and military personnel significantly affects susceptibility to infectious diseases and possibly even influences their course. This review aims to explore how the gut microbiome and stress mediators (such as catecholamines and corticosteroids) might impact the leptospirosis disease course. The review opens new horizons for research by elucidating the connections between the gut microbiome, stress, and leptospirosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.